Unknown OBSERVATIONAL NCT03245957

HDL Dysfunction During the Acute Stage of Stroke (RUSH)

Sponsor: Centre Hospitalier Universitaire de la Réunion

Interventions Haemorrhagic stroke Ischemic stroke

Updated 11 times since 2017 Last updated: Mar 6, 2019 Started: Oct 20, 2017 Primary completion: Oct 31, 2019 Completion: Mar 31, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03245957, this observational or N/A phase trial focuses on Stroke, Acute and remains ongoing. Sponsored by Centre Hospitalier Universitaire de la Réunion, it has been updated 11 times since 2017, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

11 versions recorded

Sep 2025 — Present [monthly]

Unknown
Sep 2024 — Sep 2025 [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Oct 2021 — Jul 2024 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
Jan 2021 — Oct 2021 [monthly]

Recruiting

▶ Show 6 earlier versions

Apr 2019 — Jan 2021 [monthly]

Recruiting
Jun 2018 — Apr 2019 [monthly]

Recruiting
Apr 2018 — Jun 2018 [monthly]

Recruiting

Phase: NA → None
Jan 2018 — Apr 2018 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Sep 2017 — Jan 2018 [monthly]

Not Yet Recruiting NA
Aug 2017 — Sep 2017 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centre Hospitalier Universitaire de la Réunion
Institut National de la Santé Et de la Recherche Médicale, France

Data source: Centre Hospitalier Universitaire de la Réunion

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Saint-Pierre, Reunion